Sepsis is a complex and severe syndrome associated with a dysregulated immune response against infection, affecting more than 30 million patients worldwide. Detection in the emergency department and early therapeutic intervention can reduce the mortality associated with sepsis.

The haematology laboratory has a vital role to play in rapidly identifying septic patients or those who are at high risk of developing sepsis. Recently, a new sepsis biomarker, the Early Sepsis Indicator (ESId), which is based on monocytes’ variability in sepsis, became available on a routine haematology analyzer from Beckman Coulter. The webinar discusses the performance of Early Sepsis Indicator, demonstrated in large clinical trials, and reviews monocytes’ role in sepsis pathogenesis, helping understand the science behind ESId.

Participants will learn:

• Sepsis healthcare burden and diagnostic challenge

• Performance of Early Sepsis Indicator, a new biomarker to aid in sepsis detection in the emergency department

• Scientific insights into the role of monocytes in sepsis